Register a trial

The ANZCTR website is back online for trial registration and updates. We apologise for any inconvenience caused while the site was inactive.



Reset your password and enable multi-factor authentication (MFA)


For ANZCTR account holders: to help ensure the cyber safety of your account, you’ll need to reset your password and set-up multi-factor authentication (MFA) as per the instructions below.


  1. Go to the Login page, click ‘reset password’ and follow the instructions.
  2. Check your email for the link to set a new password.
  3. Create a new password that meets requirements. New passwords must include at least one lowercase letter, one uppercase letter, one number and one special character (e.g. !#$%&@).
  4. Return to the Login page and enter your new password. A verification code will be sent to your email.
  5. Check your email for the code and enter it on the Login page. If the code is entered incorrectly, you can re-enter the correct one or request a new one.

Learn more about MFA and its importance on the Australian Signals Directorate website.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/study/NCT03222011




Registration number
NCT03222011
Ethics application status
Date submitted
6/07/2017
Date registered
19/07/2017

Titles & IDs
Public title
Stricture Definition and Treatment (STRIDENT) Endoscopic Therapy Study
Scientific title
Stricture Definition and Treatment (STRIDENT) Endoscopic Therapy Study
Secondary ID [1] 0 0
StVincentsMelbourneSTRIDENT2
Universal Trial Number (UTN)
Trial acronym
STRIDENT
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Crohn Disease 0 0
Inflammatory Bowel Diseases 0 0
Stricture; Bowel 0 0
Condition category
Condition code
Oral and Gastrointestinal 0 0 0 0
Inflammatory bowel disease
Inflammatory and Immune System 0 0 0 0
Other inflammatory or immune system disorders
Oral and Gastrointestinal 0 0 0 0
Crohn's disease
Other 0 0 0 0
Research that is not of generic health relevance and not applicable to specific health categories listed above

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Treatment: Surgery - Standard (single) endoscopic stricture dilatation
Treatment: Surgery - Intensive endoscopic stricture dilatation

Active comparator: Standard endoscopic therapy - Single endoscopic dilatation

Experimental: Intensive endoscopic therapy - 3 endoscopic dilatations 3 weeks apart and possible needle knife strictureplasty


Treatment: Surgery: Standard (single) endoscopic stricture dilatation
single endoscopic stricture dilatation

Treatment: Surgery: Intensive endoscopic stricture dilatation
3 endoscopic dilatations 3 weeks apart and possible needle knife strictureplasty
Intervention code [1] 0 0
Treatment: Surgery
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
Improvement in obstructive symptoms using the Obstructive Symptom Score (OSS).
Assessment method [1] 0 0
The Obstructive Symptom Score (OSS) is a composite measure of the total number of days of obstructive abdominal pain and the severity over a fourteen-day period using a 5-point Likert scale. (no pain, mild, moderate, severe, unbearable)
Timepoint [1] 0 0
6 months
Secondary outcome [1] 0 0
Improvement in obstructive symptoms using the Obstructive Symptom Score (OSS).
Assessment method [1] 0 0
The Obstructive Symptom Score (OSS) is a composite measure of the total number of days of obstructive abdominal pain and the severity over a fourteen-day period using a 5-point Likert scale. (no pain, mild, moderate, severe, unbearable)
Timepoint [1] 0 0
3, 6 and 12 months
Secondary outcome [2] 0 0
Improvement in imaging parameters
Assessment method [2] 0 0
MRI and intestinal ultrasound
Timepoint [2] 0 0
6 months
Secondary outcome [3] 0 0
Improvement in endoscopic features
Assessment method [3] 0 0
Increased patency of strictures on endoscopy
Timepoint [3] 0 0
6 months
Secondary outcome [4] 0 0
Avoidance of surgery
Assessment method [4] 0 0
Requirement for surgical resection of stricture
Timepoint [4] 0 0
6 months
Secondary outcome [5] 0 0
Improvement in patient reported outcomes (PROs)
Assessment method [5] 0 0
IBDQ
Timepoint [5] 0 0
6 months
Secondary outcome [6] 0 0
Improvement in patient reported outcomes (PROs)
Assessment method [6] 0 0
SF36
Timepoint [6] 0 0
6 months
Secondary outcome [7] 0 0
Technical success of procedure
Assessment method [7] 0 0
Successful endoscopic procedure
Timepoint [7] 0 0
At time of procedure

Eligibility
Key inclusion criteria
* Inflammatory bowel disease patients with intestinal stricture(s) identified on CT, MRI or endoscopy.
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
* Acute bowel obstruction requiring urgent surgical intervention
* Deemed by treating physician to have high risk of acute bowel obstruction
* Concurrent active perianal sepsis
* Internal fistulising disease in association with strictures (entero-enteric stulas)
* Low rectal or anal strictures
* Evidence of dysplasia or malignancy from stricture biopsies or adjacent mucosal biopsies
* Patients for whom endoscopy is not suitable due to co-morbidities or clinical state
* Inability to give informed consent
* Suspected perforation of the gastrointestinal tract
* Pregnancy
* Inability to undergo MRI small bowel due to a contraindication.

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Parallel
Other design features
Phase
Not applicable
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
UNKNOWN
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
9/10/2017
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
1/02/2021
Actual
Sample size
Target
30
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
VIC
Recruitment hospital [1] 0 0
St. Vincent's Hospital Melbourne - Melbourne
Recruitment postcode(s) [1] 0 0
3065 - Melbourne

Funding & Sponsors
Primary sponsor type
Other
Name
St Vincent's Hospital Melbourne
Country
Other collaborator category [1] 0 0
Other
Name [1] 0 0
Australasian Gastro Intestinal Research Foundation
Country [1] 0 0

Ethics approval
Ethics application status

Summary
Brief summary
Trial website
Public notes

Contacts
Principal investigator
Name 0 0
Emily Wright, MBBS PhD
Address 0 0
St Vincent's Hospital Melbourne
Country 0 0
Phone 0 0
Email 0 0
Contact person for public queries
Name 0 0
Julien Schulberg, MBBS
Address 0 0
Country 0 0
Phone 0 0
+61 3 92312211
Email 0 0
stridentstudy@svha.org.au
Contact person for scientific queries

Data sharing statement


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

No documents have been uploaded by study researchers.


Results not provided in https://clinicaltrials.gov/study/NCT03222011